搜索
Kyverna Therapeutics Inc
KYTX添加自选
6.990USD
-0.080-1.13%
收盘 09-24 16:00（美东）
424.99M总市值
亏损市盈率 TTM
股东统计
更新时间: 5月10日 周日
更新时间: 5月10日 周日
持股股东
股东类型
持股股东
持股股东
占比
VV Manager LLC
7.86%
Westlake Village BioPartners
7.66%
GordonMD Global Investments LP
7.22%
Gilead Sciences, Inc
6.79%
Northpond Ventures, LLC
5.70%
其他
64.77%
持股股东
持股股东
占比
VV Manager LLC
7.86%
Westlake Village BioPartners
7.66%
GordonMD Global Investments LP
7.22%
Gilead Sciences, Inc
6.79%
Northpond Ventures, LLC
5.70%
其他
64.77%
股东类型
持股股东
占比
Investment Advisor
28.26%
Venture Capital
23.27%
Hedge Fund
14.62%
Corporation
6.82%
Research Firm
2.70%
Investment Advisor/Hedge Fund
2.67%
Private Equity
2.41%
Bank and Trust
0.23%
Individual Investor
0.06%
其他
18.96%
机构持股
更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
285
46.70M
77.15%
+223.53K
2025Q4
261
32.85M
57.51%
-9.51M
2025Q3
249
27.63M
63.88%
-17.77M
2025Q2
249
34.71M
80.31%
-15.16M
2025Q1
241
34.71M
80.32%
-14.73M
2024Q4
219
37.31M
86.43%
-9.28M
2024Q3
197
37.54M
87.00%
-4.76M
2024Q2
169
41.21M
95.55%
+9.91M
2024Q1
122
39.94M
92.66%
+25.83M
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
VV Manager LLC
4.78M
7.9%
+253.14K
+5.60%
Mar 15, 2026
Westlake Village BioPartners
4.66M
7.71%
+133.33K
+2.95%
Dec 31, 2025
GordonMD Global Investments LP
4.39M
7.27%
+1.33M
+43.59%
Dec 31, 2025
Gilead Sciences, Inc
4.13M
6.83%
--
--
Dec 31, 2025
Northpond Ventures, LLC
3.47M
5.74%
+211.40K
+6.49%
Dec 31, 2025
Bain Capital Life Sciences Investors, LLC
3.11M
5.15%
-258.37K
-7.67%
Dec 31, 2025
Deerfield Management Company, L.P.
2.00M
3.31%
+2.00M
--
Dec 31, 2025
T. Rowe Price Associates, Inc.
1.71M
2.83%
+250.42K
+17.15%
Dec 31, 2025
Adage Capital Management, L.P.
1.67M
2.76%
+1.67M
--
Dec 31, 2025
查看更多
ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
ProShares Ultra Nasdaq Biotechnology
0.04%
iShares Micro-Cap ETF
0.03%
Invesco Nasdaq Biotechnology ETF
0.03%
iShares Biotechnology ETF
0.01%
Avantis US Small Cap Equity ETF
0.01%
iShares Morningstar Small-Cap ETF
0%
First Trust Multi-Manager Small Cap Opportunities ETF
0%
Schwab U.S. Small-Cap ETF
0%
iShares Health Innovation Active ETF
0%
Proshares Ultra Russell 2000
0%
查看更多
ProShares Ultra Nasdaq Biotechnology
占比0.04%
iShares Micro-Cap ETF
占比0.03%
Invesco Nasdaq Biotechnology ETF
占比0.03%
iShares Biotechnology ETF
占比0.01%
Avantis US Small Cap Equity ETF
占比0.01%
iShares Morningstar Small-Cap ETF
占比0%
First Trust Multi-Manager Small Cap Opportunities ETF
占比0%
Schwab U.S. Small-Cap ETF
占比0%
iShares Health Innovation Active ETF
占比0%
Proshares Ultra Russell 2000
占比0%